Flucelvax Preservative-Free Quadrivalent Interactions
There are 295 drugs known to interact with Flucelvax Preservative-Free Quadrivalent (influenza virus vaccine, inactivated), along with 4 disease interactions. Of the total drug interactions, 1 is major, 289 are moderate, and 5 are minor.
- View all 295 medications that may interact with Flucelvax Preservative-Free Quadrivalent
- View Flucelvax Preservative-Free Quadrivalent disease interactions (4)
Most frequently checked interactions
View interaction reports for Flucelvax Preservative-Free Quadrivalent (influenza virus vaccine, inactivated) and the medicines listed below.
- aspirin
- azithromycin
- benzonatate
- Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- bupropion
- calcium carbonate
- celecoxib
- CoQ10 (ubiquinone)
- Cosamin DS (chondroitin / glucosamine)
- dutasteride
- hydroxyurea
- iron sucrose
- levocetirizine
- levothyroxine
- lisdexamfetamine
- lisinopril
- melatonin
- Melatonin Time Release (melatonin)
- metoprolol
- milk thistle
- Moderna COVID-19 Vaccine (COVID-19 mRNA (Moderna) vaccine)
- multivitamin
- naloxone
- Nucynta (tapentadol)
- Nucynta ER (tapentadol)
- omeprazole
- pantoprazole
- pregabalin
- promethazine
- ranitidine
Flucelvax Preservative-Free Quadrivalent disease interactions
There are 4 disease interactions with Flucelvax Preservative-Free Quadrivalent (influenza virus vaccine, inactivated) which include:
Report options
QR code containing a link to this page
More about Flucelvax Preservative-Free Quadrivalent (influenza virus vaccine, inactivated)
- Flucelvax Preservative-Free Quadrivalent consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.